文献速递贫血与红细胞疾病

婴幼儿Diamond-Blackfan贫血综合征铁过载管理:法意联合研究

Management of Iron Overload in Infants and Toddlers With Diamond-Blackfan Anemia Syndrome: A French-Italian Study.
PubMed 文献 · Am J Hematol · 2026-05-11

该回顾性多中心研究基于法国和意大利DBAS国家登记库,筛查167例输血依赖的DBAS患者,其中64例(38%)在3岁前开始祛铁治疗(中位年龄18个月)。祛铁治疗与血清铁蛋白水平显著下降相关(每年-11%,p<0.001),5-6岁时43%的患者铁蛋白<500 ng/mL,且无人超过2000 ng/mL。这些真实世界数据支持3岁以下输血依赖DBAS患者祛铁治疗的可行性、耐受性和有效性,可预防心脏铁过载。

要点

  • 3岁前开始祛铁可显著降低血清铁蛋白(每年-11%,p<0.001)。
  • 5-6岁时43%患者铁蛋白<500 ng/mL,无人超过2000 ng/mL。
  • 首次评估时45%患者存在严重肝铁过载,但无心肌铁过载。

核心结论

  • 真实世界数据支持3岁以下输血依赖DBAS患者祛铁治疗的可行性、耐受性和有效性。
  • 祛铁治疗可预防心脏铁过载,可能为其他输血依赖性贫血的婴幼儿铁过载管理提供参考。

研究设计与样本

  • 回顾性、多中心研究,收集法国和意大利DBAS国家登记库数据。
  • 共筛查167例输血依赖的DBAS患者,其中64例(38%)在3岁前开始祛铁治疗。

主要发现

  • 64例患者开始祛铁的中位年龄为18个月。
  • 祛铁指征为血清铁蛋白≥500 ng/mL(中位1340 ng/mL)且输血次数>10次。
  • 去铁斯若(Deferasirox)是最常用祛铁剂(63%),其次为去铁胺(35%)。
  • 祛铁治疗与血清铁蛋白水平显著下降相关(每年-11%,p<0.001)。
  • 5-6岁时28例患者铁蛋白可评估:43%<500 ng/mL,无人>2000 ng/mL。

关键数值与推荐

  • 祛铁指征:血清铁蛋白≥500 ng/mL且输血次数>10次(原文依据)。

临床怎么用

  • 对于3岁以下输血依赖的DBAS患儿,可考虑开始祛铁治疗,但需个体化评估。
  • 祛铁治疗期间应监测血清铁蛋白和肝铁浓度,心脏铁过载风险较低。

局限性

  • 回顾性研究设计,存在选择偏倚和信息偏倚可能。
  • 样本量有限,部分患者数据不完整(如5-6岁时仅28例有铁蛋白数据)。
  • 结果主要来自DBAS患者,外推至其他贫血需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diamond-Blackfan Anemia Syndrome (DBAS) is a rare congenital anemia often requiring chronic red blood cell transfusions from infancy. Without appropriate chelation, iron overload develops early and may be severe; however, no data are available on chelation in patients under 3 years of age. To address this, we conducted a retrospective, multicenter study collecting data from the French and Italian DBAS national registries. A total of 167 transfused DBAS patients were screened. Of these, 64 (38%) initiated chelation before the age of three (median: 18 months). Indications for chelation were a serum ferritin ≥ 500 ng/mL (median: 1340 ng/mL) and more than 10 transfusions. Deferasirox was the most frequently used chelator (63%), followed by deferoxamine (35%). Chelation was associated with a significant reduction in serum ferritin levels (-11% per year; p < 0.001). At 5-6 years of age, ferritin level was available for 28 patients: 43% had levels < 500 ng/mL, and none exceeded 2000 ng/mL. Liver iron concentration was assessed in 31/64 patients (48%) at a median age of 3.2 years; 45% showed severe overload at first evaluation. Among 22 patients who underwent cardiac magnetic resonance, no myocardial iron overload was detected. These real-world data support the feasibility, tolerability, and effectiveness of chelation in transfusion-dependent DBAS patients under 3 years, allowing prevention of cardiac iron overload. Although derived from DBAS, these findings may inform the management of iron overload in infants and toddlers with other transfusion-dependent anemias and support development of age-specific chelation strategies.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Torchio F, Lecalvez B, Garelli E, et al. Management of Iron Overload in Infants and Toddlers With Diamond-Blackfan Anemia Syndrome: A French-Italian Study. Am J Hematol. 2026. PMID: 42108919. doi:10.1002/ajh.70354

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。